Literature DB >> 2532469

Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats.

J P Clozel1, H Kuhn, F Hefti.   

Abstract

The goal of the present study was to describe the relative extent of vascular hypertrophy in four different types of arteries (coronary, renal, carotid, and mesenteric) of spontaneously hypertensive rats (SHR) and to evaluate the effects of long-term treatment with cilazapril, a new long-acting angiotensin-converting enzyme inhibitor on this vascular hypertrophy. For this purpose, a group of spontaneously hypertensive rats treated for four months with cilazapril (10 mg/kg orally) was compared with a group of spontaneously hypertensive rats treated with placebo. Another group of Wistar Kyoto (WKY) rats treated with placebo was used as a reference. At the end of the treatment period, the rats were perfused-fixed and morphometry of the carotid, renal, mesenteric and coronary arteries was performed. Vascular hypertrophy (increase of the thickness of the medial layer) was present in the four different types of arteries in a similar extent. Cilazapril normalized completely the arterial wall thickness:diameter ratio in the four different types of arteries. Further studies are required to determine whether this effect of cilazapril was due to the decrease of arterial blood pressure or to an effect of cilazapril on growth factors such as angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532469     DOI: 10.1016/0002-9343(89)90102-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Noradrenergic hyperinnervation may inhibit necrosis of coronary arterial smooth muscle cells in stroke-prone spontaneously hypertensive rats.

Authors:  M Kondo; T Fujiwara; T Miyazaki; M Terade; R Tabei
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

Review 2.  Innocent heart murmurs in children. Taking a diagnostic approach.

Authors:  N R Saunders
Journal:  Can Fam Physician       Date:  1995-09       Impact factor: 3.275

Review 3.  Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.

Authors:  F Deget; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

4.  Vascular protection with cilazapril.

Authors:  J P Clozel; J S Powell; H Kuhn; R K Müller; F Hefti; H R Baumgartner
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Alcohol withdrawal at home. Pilot project for frail elderly people.

Authors:  D J Evans; S D Street; D J Lynch
Journal:  Can Fam Physician       Date:  1996-05       Impact factor: 3.275

6.  Effects of bisoprolol on left ventricular hypertrophy in essential hypertension.

Authors:  E de Teresa; M González; C Camacho-Vázquez; M J Tabuenca
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

7.  Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin-angiotensin system.

Authors:  Fei Wang; Xiaohan Lu; Mi Liu; Yumei Feng; Shu-Feng Zhou; Tianxin Yang
Journal:  BMC Med       Date:  2015-11-10       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.